We are pioneering CRISPR-based microbial gene therapy
The SNIPR Biome Story
Watch our 3-min company presentation film below
Our Impact
Precision killing of bacteria has the potential to revolutionize the management of untreatable and difficult-to-treat conditions as well as complex diseases directly impacted by the human microbiota.
$50M Series A Raised
SNIPR Biome raised $50M in one of the largest Series A’s in Europe from four large European funds to advance CRISPR-based microbiome drugs to human clinical trials.
40+ Scientists
Since its inception in August 2017, SNIPR Biome has over the course of 4 years grown to a team of more than 40 - predominantly PhDs.
Several Patent Families
The SNIPR Biome scientists have made several innovative and novel discoveries which are being protected in several separate patent families – +30 of which have already granted as US patents.
“
News & Press
SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women
06.24 / Press Release
Work With Us
SNIPR Biome is the leading CRISPR Microbiome company. As a growing company we are always looking for new talents to join our team in the capital of Denmark, Copenhagen. Our main goal is to engineer microbiomes using CRISPR technology, to treat a number of serious and life-threatening diseases, ranging from IBD, Multi-drug resistant infections to cancer. The working environment is fun, fast-paced, collaborative and outcome focused. If you are curious, smart and passionate about inventing tomorrow’s medicine then drop us a line.
